LOE 908 HYDROCHLORIDE
Modify Date: 2024-01-10 09:47:28
LOE 908 HYDROCHLORIDE structure
|
Common Name | LOE 908 HYDROCHLORIDE | ||
|---|---|---|---|---|
| CAS Number | 149759-26-2 | Molecular Weight | 749.28900 | |
| Density | 1.17g/cm3 | Boiling Point | 803.7ºC at 760mmHg | |
| Molecular Formula | C41H49ClN2O9 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 439.9ºC | |
Use of LOE 908 HYDROCHLORIDEPinokalant is a broad-spectrum and non-selectivecation channel inhibitor. Pinokalant significantly reduces cortical infarct volume. Pinokalant o improves the metabolic and electrophysiologic status of the ischemic penumbra. Pinokalant reduces lesion size on magnetic resonance images in the acute phase following middle cerebral artery occlusion in rats. Pinokalant has the potential for the research of stroke. Pinokalant also shows anti-SARS-CoV-2 activity[1]. |
| Name | 2-(6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)-2-phenyl-N,N-bis[2-(2,3,4-trimethoxyphenyl)ethyl]acetamide |
|---|---|
| Synonym | More Synonyms |
| Description | Pinokalant is a broad-spectrum and non-selectivecation channel inhibitor. Pinokalant significantly reduces cortical infarct volume. Pinokalant o improves the metabolic and electrophysiologic status of the ischemic penumbra. Pinokalant reduces lesion size on magnetic resonance images in the acute phase following middle cerebral artery occlusion in rats. Pinokalant has the potential for the research of stroke. Pinokalant also shows anti-SARS-CoV-2 activity[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Pinokalant significantly reduces cortical infarct volume from 33.8 mm3 to 24.5 mm3[1]. |
| References |
| Density | 1.17g/cm3 |
|---|---|
| Boiling Point | 803.7ºC at 760mmHg |
| Molecular Formula | C41H49ClN2O9 |
| Molecular Weight | 749.28900 |
| Flash Point | 439.9ºC |
| Exact Mass | 748.31300 |
| PSA | 106.51000 |
| LogP | 6.43600 |
| Vapour Pressure | 7.33E-26mmHg at 25°C |
| Index of Refraction | 1.561 |
| unii-7j9zz971ao |
| pinokalant |
| loe 908 |